Contemporary Treatment Options for Presbyopia

Subject areas

This course counts toward the state boards and subject areas below.

Disclosure statements

(Submitting on behalf of Dr. Mile Brujuic. - SBW)

I, Mile Brujic, have no financial or proprietary interest in any of the products discussed.

I have received honoraria in the past 2 years for speaking, writing, participating in an advisory capacity, research or meeting support from: Apellis (consultant, speakers bureau), ABB Optical (received meeting support), Abbvie (consultant), Alcon (consultant, speakers bureau), Art Optical (received meeting support), Azura (consultant), Bruder Healthcare (consultant), Bausch + Lomb Health (consultant, speakers bureau), Contamac (received meeting support), CooperVision (received meeting support), CSEye (consultant), Dompe (consultant), Dopavision (consultant), Eyepromise (consultant), Glaukos (consultant), Johnson & Johnson Vision Care (received meeting support), Lentechs (received research support), Mediprint (consultant), MDElite (consultant), Nordic Pharma (consultant), Orasis (consultant, speakers bureau), Radius XR (consultant), SCOPE (consultant), Sun Pharma (speakers bureau), Tangible Science (received meeting support), Tarsus (consultant, speakers bureau), Théa Pharma (consultant), Viatris (consultant, speakers bureau), Visionix (consultant), Walman Optical (received meeting support).

I have read and will comply with the COPE requirements for course qualification.           I further agree to notify COPE in writing should any information provided, including financial/proprietary information, change at any time during the three year qualification period of this course.

I agree that I will keep my presentation free from commercial interest or bias. I will maintain independent control over the content of my presentation, so that it is balanced, objective, presented with scientific rigor and not be for the purpose of promoting products, equipment, etc. (Therefore, my presentation should not be perceived by attendees as a commercial.) I further agree that I will not change the basic content of my presentation following approval.

I agree to disclose to the audience the existence of any significant financial/professional relationships with the manufacturer(s) of any commercial product(s) and/or the provider(s) of any commercial service(s) discussed in the educational presentation. (Said relationships can include such things as grant/research support, employment, consulting and/or speakers bureau arrangements, major stock ownership, etc.) I will disclose any of these relationships, whether or not there is direct commercial support for the CE activity. This disclosure is made to provide the audience the information on which they can make judgments as to a presenter’s objectivity.

I agree to disclose the attendees; a) when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational (not FDA approved); b) any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.